Pycnogenol®, French maritime pine bark extract, improves endothelial function of hypertensive patients

Life Sciences

Volumn 74, Issue 7, 2004, Pages 855-862

  Liu, Ximing ^a   Wei, Junping ^a   Tan, Fengsen ^b   Zhou, Shengming ^c   Würthwein, Gudrun ^d   Rohdewald, Peter ^d  

^a Guanganmen Hospital   (China)

^b Gen Logistics Dept Chinese Peoples   (China)

^c Laiwu Hospital   (China)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Endothelin 1; Hypertension; Nifedipine; Prostaglandin; Pycnogenol French maritime pine bark extract

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; ELECTROLYTE; ENDOTHELIN 1; NIFEDIPINE; NITRIC OXIDE; PINUS PINASTER EXTRACT; PLACEBO; PLANT EXTRACT; PYCNOGENOL; UNCLASSIFIED DRUG; ANGIOTENSIN II; ANTITHROMBOCYTIC AGENT; FLAVONOID; PYCNOGENOLS;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; SUPPLEMENTATION; UREA NITROGEN BLOOD LEVEL; VASCULAR ENDOTHELIUM; VERTIGO; AGED; BLOOD; BLOOD ANALYSIS; BLOOD PRESSURE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; MIDDLE AGED; PHYSIOLOGY; PINE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

PINUS PINASTER;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; AGED; ANGIOTENSIN II; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOTHELIN-1; FEMALE; FLAVONOIDS; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; NITRIC OXIDE; PINUS; PLANT EXTRACTS; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 0345059061     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.07.037     Document Type: Article

References (9)

1. Araghi Nicknam M., Hosseini S., Larson D., Rohdewald P., Watson R.R. Pine bark extract reduces platelet aggregation. Integrative Medicine. 2:1999;73-77.
2. Blazso G., Gaspar R., Gábor M., Rüve H.-J., Rohdewald P. ACE inhibition and hypotensive effect of procyanidins-containing extract from the bark of Pinus pinaster sol. Pharmaceutical Pharmacology Letters. 6:1996;8-11.
3. Devaraj S., Kaul N., Schönlau F., Rohdewald P., Jialal I. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters plasma lipoprotein profile. Lipids. 37(10):2002;931-934.
4. Fitzpatrick D.F., Bing B., Rohdewald P. Endothelium-dependent vascular effects of Pycnogenol® Journal of Cardiovascular Pharmacology. 32:1998;509-515.
5. Hosseini S., Jeongmin L., Sepulveda R.T., Rohdewald P., Watson R.R. A randomized, double-blind, placebo-controlled, prospective, 16-week crossover study to determine the role of Pycnogenol® in modifying blood pressure in mildly hypertensive patients. Nutrition Research. 21:2001;1251-1260.
6. Koch R. Comparative study of Venostasin and Pycnogenol® in chronic venous insufficiency. Phytotherapy Research. 16:2002;1-5.
7. Peng Q., Wei Z., Lau B.H.S. Pycnogenol® inhibits tumor necrosis factor-(TNF-α)-induced nuclear factor κB activation, and adhesion molecule expression in human vascular endothelial cells. Cellular Molecular Life Science. 57:2000;834-841.
8. Pütter M., Grotemeyer K.H.M., Würthwein G.et al. Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol® Thrombosis Research. 95:1999;155-161.
9. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology. International Journal of Clinical Pharmacology and Therapeutics. 40(4):2002;158-168.